Valuation: Zenotech Laboratories Limited

Market Cap 2.09B 21.84M 18.86M 17.75M 16.13M 30.34M 30.79M 208M 81.59M 1.05B 82M 80.22M 3.49B P/E 2024
43.5x
P/E 2025 56.5x
Enterprise Value 1.83B 19.05M 16.46M 15.48M 14.07M 26.47M 26.86M 182M 71.18M 913M 71.54M 69.99M 3.04B EV / Sales 2024
9.27x
EV / Sales 2025 7.42x
Free-Float
15.47%
Yield 2024 *
-
Yield 2025 -
07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
04-29 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
01-23 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
01-23 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
31/10/25 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25/09/25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
28/07/25 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/03/25 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
28/01/25 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
23/10/24 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
23/10/24 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
26/07/24 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
17/05/24 Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024 CI
1 day-2.48%
1 week+5.52%
Current month+4.27%
1 month-2.66%
3 months+3.66%
6 months+2.34%
Current year+0.54%
1 week 43.01
Extreme 43.01
49.75
1 month 43
Extreme 43
49.75
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
57.9
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 23/10/2024
Director of Finance/CFO - 06/02/2014
Compliance Officer 46 11/03/2016
Director TitleAgeSince
Director/Board Member 58 08/07/2015
Chairman 67 -
Director/Board Member 42 27/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
-2.48%+5.52%-16.32%-13.03% 30.33M
+3.60%+0.88%+75.59%+124.32% 1,093B
+3.33%+4.35%+53.82%+57.17% 653B
+3.43%+3.53%+25.34%+72.45% 458B
+0.61%-0.82%+39.32%+42.55% 355B
+0.05%+1.11%+24.46%+39.53% 294B
+0.65%+1.37%+0.68%+11.13% 248B
+1.41%+2.65%+45.34%+62.43% 230B
-1.10%-2.22%-15.86%-53.56% 203B
+3.25%+5.65%+21.57%+89.04% 178B
Average +0.15%+1.90%+25.39%+43.20% 371.05B
Weighted average by Cap. +0.03%+1.45%+43.57%+68.75%

Financials

2024 2025
Net sales 368M 3.84M 3.32M 3.12M 2.84M 5.34M 5.41M 36.62M 14.35M 184M 14.42M 14.11M 613M 391M 4.08M 3.52M 3.32M 3.01M 5.67M 5.75M 38.9M 15.24M 196M 15.32M 14.99M 651M
Net income 82.99M 866K 748K 704K 640K 1.2M 1.22M 8.26M 3.24M 41.51M 3.25M 3.18M 138M 56.13M 586K 506K 476K 433K 814K 826K 5.58M 2.19M 28.07M 2.2M 2.15M 93.51M
Net Debt -197M -2.05M -1.77M -1.67M -1.52M -2.85M -2.9M -19.59M -7.68M -98.47M -7.71M -7.55M -328M -267M -2.79M -2.41M -2.26M -2.06M -3.87M -3.93M -26.57M -10.41M -134M -10.46M -10.24M -445M
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
228
Date Price Change Volume
19/08/26 46.44 -2.48% 9,149
18/08/26 ₹47.62 +0.44% 14,113
17/08/26 ₹47.41 +8.64% 39,544
14/08/26 ₹43.64 -0.89% 1,652
13/08/26 ₹44.03 +0.05% 3,736
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock